Dr. Azab is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1726 Shawano Ave
Green Bay, WI 54303Phone+1 920-496-4700
Education & Training
Loma Linda University Health Education ConsortiumFellowship, Gastroenterology, 2018
Kasr El Aini Cairo FomClass of 2011
Certifications & Licensure
OK State Medical License 2024 - 2025
WI State Medical License 2021 - 2025
CA State Medical License 2018 - 2021
NV State Medical License 2015 - 2018- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- Pre-left ventricular assist device endoscopic evaluation does not reduce the risk of later gastrointestinal bleeding: a multicenter study.Jiahao Peng, Samanthika Devalaraju, Mohamed Azab, William T Cates, Molly Stone
Annals of Gastroenterology. 2024-04-10 - Moving-Target Defense in Depth: Pervasive Self- and Situation-Aware VM Mobilization across Federated Clouds in Presence of Active Attacks.Yousra Magdy, Mohamed Azab, Amal Hamada, Mohamed R M Rizk, Nayera Sadek
Sensors. 2022-12-06 - UAV-Based Privacy-Preserved Trustworthy Seamless Service Agility for NextG Cellular Networks.Mai A Abdel-Malek, Muhammad M Sayed, Mohamed Azab
Sensors. 2022-04-02
Abstracts/Posters
- Progression Free Survival (PFS), and Event Free Survival (EFS) from a Global Randomized Phase 3 Study of Guadecitabine (G) Vs Treatment Choice (TC) in 815 Patients wit...Mohammad Azab, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Landmark Response and Survival Analyses from 102 MDS and CMML Patients Treated with Guadecitabine in a Phase 2 Study Showing That Maximum Response and Survival Is Best...Mohammad Azab, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Durable Remission and Long-Term Survival in Relapsed/Refractory (r/r) AML Patients Treated with Guadecitabine, Median Survival Not Reached for Responders after Long Te...Mohammad Azab, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
